SCHEMBL560320

SCHEMBL560320

C=[C]c1ccc(O)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11513337 0.73 CA3 (0.58)
SCHEMBL673609 0.73 APP (0.74)
SCHEMBL14400750 0.73 APP (0.74)
Hydroquinone SCHEMBL18095025 0.71 HSD17B10 (0.80)
Hydroquinone SCHEMBL460669 0.71 ALOX15 (1.00)
Hydroquinone SCHEMBL11511669 0.71 ALOX15 (1.00)
Hydroquinone SCHEMBL15516 0.71
4-Cyanophenol SCHEMBL4820911 0.69 CA2 (0.84)
SCHEMBL6443716 0.69 APP (0.43)
SCHEMBL4007018 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114634705-A Heat and sound insulation blanket for vehicle and preparation method thereof 张影 2022-06-17 CN claimed
EP-1009738-B1 SUBSTITUTED OXINDOLE DERIVATIVES AS PROTEIN TYROSINE KINASE AND AS PROTEIN SERINE/THREONINE KINASE INHIBITORS GLAXO GROUP LTD (GB) 2004-05-19 EP claimed
US-6541503-B2 Preventing chemotherapy induced alopecia. SMITHKLINE BEECHAM CORPORATION 2003-04-01 US claimed
US-20030004351-A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors SMITHKLINE BEECHAM CORPORATION 2003-01-02 US claimed
CN-114634705-A Heat and sound insulation blanket for vehicle and preparation method thereof 张影 2022-06-17 CN disclosed
US-10274500-B2 Characterization of subvisible particles using a particle analyzer BAXALTA INCORPORATED (US) 2019-04-30 US disclosed
US-9645128-B2 Substituted imidazo[1,2-A]pyrazines for measuring a transcription activity JNC CORPORATION (JP) 2017-05-09 US disclosed
US-20170121755-A1 COELENTERAZINE ANALOGS JNC CORPORATION 2017-05-04 US disclosed
US-9567623-B2 Coelenterazine analogs JNC CORPORATION (JP) 2017-02-14 US disclosed
US-9346767-B2 Substituted pyrazines and a process for producing the same JNC CORPORATION (JP) 2016-05-24 US disclosed
US-20150344936-A1 COELENTERAZINE ANALOGS AND MANUFACTURING METHOD THEREOF TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-12-03 US disclosed
US-9151739-B2 Coelenterazine analogs and manufacturing method thereof JNC CORPORATION (JP) 2015-10-06 US disclosed
US-8642281-B2 Coelenterazine analogues and coelenteramide analogues JNC CORPORATION (JP) 2014-02-04 US disclosed
US-20140024058-A1 COELENTERAZINE ANALOGS AND MANUFACTURING METHOD THEREOF TOKYO INSTITUTE OF TECHNOLOGY (JP) 2014-01-23 US disclosed
US-8546568-B2 Coelenterazine analogs and manufacturing method thereof JNC CORPORATION (JP) 2013-10-01 US disclosed
US-20130177933-A1 Characterization of Subvisible Particles Using a Particle Analyzer BAXTER HEALTHCARE SA (CH) 2013-07-11 US disclosed
US-20120232272-A1 PROCESS FOR PRODUCING v-COELENTERAZINE COMPOUNDS NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (JP) 2012-09-13 US disclosed
US-20120035070-A1 COELENTERAZINE ANALOGS AND MANUFACTURING METHOD THEREOF TOKYO INSTITUTE OF TECHNOLOGY (JP) 2012-02-09 US disclosed
US-20110244481-A1 COELENTERAZINE ANALOGUES AND COELENTERAMIDE ANALOGUES JNC CORPORATION (JP) 2011-10-06 US disclosed
EP-1009738-B1 SUBSTITUTED OXINDOLE DERIVATIVES AS PROTEIN TYROSINE KINASE AND AS PROTEIN SERINE/THREONINE KINASE INHIBITORS GLAXO GROUP LTD (GB) 2004-05-19 EP disclosed